wet- en regelgeving Cancer drugs’ share of new FDA approvals doubled this decade thanks to smarter R&D: report 5 september 2019FiercePharma
marketing Content en communicatie: dé trends & tips voor de tweede helft van 2019 2 september 2019Frankwatching.nl
marketing Get a Refresh on the What, Why, Where, and How of Content Marketing 2 september 2019Content Marketing Institute
onderzoek Novartis phase III ASCLEPIOS I & II studies of ofatumumab versus Aubagio to treat relapsing forms MS meets primary endpoints 2 september 2019Pharma Biz
onderzoek OPKO completes phase 3 study for somatrogon to treat growth hormone deficiency in children 2 september 2019Pharma Biz
onderzoek AstraZeneca presents strong Phase 3 Brilinta data for reducing CV risk 2 september 2019InPharm.com
